2022
DOI: 10.33425/2639-9512.1070
|View full text |Cite
|
Sign up to set email alerts
|

Novel Bioregenerative Options for Chondrocyte Restoration in Osteoarthritis.

Abstract: Cartilage diseases refer to an umbrella of joint disorders, joint injuries and cartilage tumors that are largely characterized by degenerative chondrocyte changes in joints.Osteoarthritis(OA) is the most common form of chronic cartilage diseases, affecting 250 million people and is the fourth leading cause of disability worldwide. The widely used pharmacological treatments for OA have shown limited benefits, and further studies are required. Stem cells have been proposed as regenerative cell therapy for OA to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Mitochondrial therapy, especially tissue-specific mitochondrialbased therapy, is becoming an encouraging approach to regenerative medicine. A recently published review demonstrated the growing interest in stem cell-based bioregenerative therapy conducting the regeneration of new chondrocytes [50]. Nalapko et al (2022) state that multiple preclinical and clinical trials proved that MSCs and chondrocyte stem cell-based agents are potentially useful regenerative technologies for patients with osteoarthritis [50].…”
Section: Mitochondrial Dysfunction In Rheumatoid Arthritismentioning
confidence: 99%
“…Mitochondrial therapy, especially tissue-specific mitochondrialbased therapy, is becoming an encouraging approach to regenerative medicine. A recently published review demonstrated the growing interest in stem cell-based bioregenerative therapy conducting the regeneration of new chondrocytes [50]. Nalapko et al (2022) state that multiple preclinical and clinical trials proved that MSCs and chondrocyte stem cell-based agents are potentially useful regenerative technologies for patients with osteoarthritis [50].…”
Section: Mitochondrial Dysfunction In Rheumatoid Arthritismentioning
confidence: 99%
“…2 While growing evidence suggests that OA involves a complex pathogenesis of structural changes to the cartilage, bone, ligaments, and muscles, 3,4 articular cartilage changes are the most studied feature of OA progression. 5,6 Early stages of OA are characterized by cartilage changes including increased hydration, proteoglycan loss, and disruption of collagen fibers, while later changes include dehydration and thinning of the cartilage, resulting in denudation of the underlying bone. 7 Cartilage thickness and volume changes measured with magnetic resonance imaging (MRI) have proven useful in predicting OA progression.…”
Section: Introductionmentioning
confidence: 99%